Minireviews
World J Hepatol
9(25):1043-1053.
Published online Sep 8, 2017.
doi: 10.4254/wjh.v9.i25.1043
Abstract (1250)
|
Core Tip (1229)
|
Full Article (HTML) (3883)
|
Tables (1-3) (487)
|
Full Article (PDF)-1379K (616)
|
Audio-718K (17)
|
Peer-Review Report-94K (202)
|
Answering Reviewers-128K (216)
|
Received: 05/27/2017
|
Revised: 07/13/2017
|
Accepted: 08/04/2017
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (15)
|
Total Visits (13152)
|
Similar Articles (386)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
9(25):1054-1063.
Published online Sep 8, 2017.
doi: 10.4254/wjh.v9.i25.1054
Abstract (1309)
|
Core Tip (1096)
|
Full Article (HTML) (4436)
|
Full Article (PDF)-1369K (763)
|
Audio-468K (14)
|
Peer-Review Report-78K (262)
|
Answering Reviewers-64K (212)
|
Received: 01/26/2017
|
Revised: 07/18/2017
|
Accepted: 08/16/2017
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (18)
|
Total Visits (14180)
|
Similar Articles (183)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Real-world efficacy of daclatasvir and asunaprevir with respect to resistance-associated substitutions

World J Hepatol
9(25):1064-1072.
Published online Sep 8, 2017.
doi: 10.4254/wjh.v9.i25.1064
Abstract (1371)
|
Core Tip (1125)
|
Full Article (HTML) (4884)
|
Figures (1-2) (452)
|
Tables (1-2) (445)
|
Full Article (PDF)-1444K (387)
|
Audio-2584K (19)
|
Peer-Review Report-98K (188)
|
Answering Reviewers-81K (157)
|
Received: 03/16/2017
|
Revised: 05/17/2017
|
Accepted: 07/17/2017
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (9)
|
Total Visits (17305)
|
Similar Articles (8)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
CD4+ T cells and natural killer cells: Biomarkers for hepatic fibrosis in human immunodeficiency virus/hepatitis C virus-coinfected patients

World J Hepatol
9(25):1073-1080.
Published online Sep 8, 2017.
doi: 10.4254/wjh.v9.i25.1073
Abstract (1256)
|
Core Tip (1121)
|
Full Article (HTML) (3462)
|
Figures (1-3) (447)
|
Tables (1-2) (450)
|
Full Article (PDF)-1721K (459)
|
Audio-547K (35)
|
Peer-Review Report-82K (172)
|
Answering Reviewers-134K (164)
|
Received: 01/04/2017
|
Revised: 04/29/2017
|
Accepted: 05/24/2017
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (16884)
|
Similar Articles (124)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open